228 related articles for article (PubMed ID: 15285718)
1. Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria.
Leissring MA; Farris W; Wu X; Christodoulou DC; Haigis MC; Guarente L; Selkoe DJ
Biochem J; 2004 Nov; 383(Pt. 3):439-46. PubMed ID: 15285718
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
[TBL] [Abstract][Full Text] [Related]
3. Insulin-degrading enzyme.
Authier F; Posner BI; Bergeron JJ
Clin Invest Med; 1996 Jun; 19(3):149-60. PubMed ID: 8724818
[TBL] [Abstract][Full Text] [Related]
4. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.
Farris W; Mansourian S; Leissring MA; Eckman EA; Bertram L; Eckman CB; Tanzi RE; Selkoe DJ
Am J Pathol; 2004 Apr; 164(4):1425-34. PubMed ID: 15039230
[TBL] [Abstract][Full Text] [Related]
5. Insulysin cleaves the APP cytoplasmic fragment at multiple sites.
Venugopal C; Pappolla MA; Sambamurti K
Neurochem Res; 2007 Dec; 32(12):2225-34. PubMed ID: 17701350
[TBL] [Abstract][Full Text] [Related]
6. Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues.
Kuo WL; Montag AG; Rosner MR
Endocrinology; 1993 Feb; 132(2):604-11. PubMed ID: 7678795
[TBL] [Abstract][Full Text] [Related]
7. Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes.
Affholter JA; Hsieh CL; Francke U; Roth RA
Mol Endocrinol; 1990 Aug; 4(8):1125-35. PubMed ID: 2293021
[TBL] [Abstract][Full Text] [Related]
8. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
9. Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines.
Takayama S; Krajewski S; Krajewska M; Kitada S; Zapata JM; Kochel K; Knee D; Scudiero D; Tudor G; Miller GJ; Miyashita T; Yamada M; Reed JC
Cancer Res; 1998 Jul; 58(14):3116-31. PubMed ID: 9679980
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial targeting of the human peptide methionine sulfoxide reductase (MSRA), an enzyme involved in the repair of oxidized proteins.
Hansel A; Kuschel L; Hehl S; Lemke C; Agricola HJ; Hoshi T; Heinemann SH
FASEB J; 2002 Jun; 16(8):911-3. PubMed ID: 12039877
[TBL] [Abstract][Full Text] [Related]
11. Yeast as a tractable genetic system for functional studies of the insulin-degrading enzyme.
Kim S; Lapham AN; Freedman CG; Reed TL; Schmidt WK
J Biol Chem; 2005 Jul; 280(30):27481-90. PubMed ID: 15944156
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants for the intracellular localization of the isozymes of mammalian hexokinase: intracellular localization of fusion constructs incorporating structural elements from the hexokinase isozymes and the green fluorescent protein.
Sui D; Wilson JE
Arch Biochem Biophys; 1997 Sep; 345(1):111-25. PubMed ID: 9281318
[TBL] [Abstract][Full Text] [Related]
13. Cloning and expression of rat pancreatic beta-cell malonyl-CoA decarboxylase.
Voilley N; Roduit R; Vicaretti R; Bonny C; Waeber G; Dyck JR; Lopaschuk GD; Prentki M
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):213-7. PubMed ID: 10229677
[TBL] [Abstract][Full Text] [Related]
14. Insulin-Degrading Enzyme Interacts with Mitochondrial Ribosomes and Respiratory Chain Proteins.
Yilmaz A; Guerrera C; Waeckel-Énée E; Lipecka J; Bertocci B; van Endert P
Biomolecules; 2023 May; 13(6):. PubMed ID: 37371470
[TBL] [Abstract][Full Text] [Related]
15. Cloning and expression of the cDNA for a Drosophila insulin-degrading enzyme.
Kuo WL; Gehm BD; Rosner MR
Mol Endocrinol; 1990 Oct; 4(10):1580-91. PubMed ID: 2126597
[TBL] [Abstract][Full Text] [Related]
16. Functional human insulin-degrading enzyme can be expressed in bacteria.
Chesneau V; Rosner MR
Protein Expr Purif; 2000 Jun; 19(1):91-8. PubMed ID: 10833395
[TBL] [Abstract][Full Text] [Related]
17. Characterization of insulin-degrading enzyme-mediated cleavage of Aβ in distinct aggregation states.
Hubin E; Cioffi F; Rozenski J; van Nuland NA; Broersen K
Biochim Biophys Acta; 2016 Jun; 1860(6):1281-90. PubMed ID: 26968463
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
Cordes CM; Bennett RG; Siford GL; Hamel FG
Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
[TBL] [Abstract][Full Text] [Related]
19. Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway.
Kuo WL; Gehm BD; Rosner MR
Mol Endocrinol; 1991 Oct; 5(10):1467-76. PubMed ID: 1775131
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal sequence directs import of mitochondrial alanine aminotransferase into mitochondria.
Metón I; Egea M; Fernández F; Eraso MC; Baanante IV
FEBS Lett; 2004 May; 566(1-3):251-4. PubMed ID: 15147904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
